Nurix Therapeutics Inc (NRIX)
13.58
-0.01
(-0.07%)
USD |
NASDAQ |
Apr 22, 16:00
13.57
-0.01
(-0.07%)
After-Hours: 20:00
Nurix Therapeutics Net Income (TTM): -144.73M for Feb. 29, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| February 29, 2024 | -144.73M |
| November 30, 2023 | -143.95M |
| August 31, 2023 | -148.71M |
| May 31, 2023 | -157.44M |
| February 28, 2023 | -178.56M |
| November 30, 2022 | -180.36M |
| August 31, 2022 | -171.34M |
| May 31, 2022 | -154.47M |
| Date | Value |
|---|---|
| February 28, 2022 | -135.45M |
| November 30, 2021 | -117.19M |
| August 31, 2021 | -99.41M |
| May 31, 2021 | -89.09M |
| February 28, 2021 | -55.13M |
| November 30, 2020 | -43.24M |
| August 31, 2020 | -36.85M |
| May 31, 2020 | -20.76M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-180.36M
Minimum
Nov 2022
-20.76M
Maximum
May 2020
-117.29M
Average
-139.70M
Median
Net Income (TTM) Benchmarks
| Gilead Sciences Inc | 5.664B |
| ALX Oncology Holdings Inc | -160.80M |
| Vanda Pharmaceuticals Inc | 2.509M |
| GlycoMimetics Inc | -36.90M |
| Immunic Inc | -93.61M |